Inari Medical Inc (STU:IM7)
€ 48.2 -1.6 (-3.21%) Market Cap: 2.84 Bil Enterprise Value: 2.76 Bil PE Ratio: 0 PB Ratio: 6.69 GF Score: 80/100

Inari Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 05:45PM GMT
Release Date Price: €53 (-9.40%)
Allen Gong
JPMorgan - Analyst

Okay. Good morning, everyone. My name is Allen Gong. I work on the medical supplies and devices team here at JPMorgan. And it's my pleasure to be introducing the management team of Inari today. We're going to start off with some prepared remarks from CEO, Drew Hykes, before we open up to a broader Q&A with some other members of the management team. Drew, if you want to start us off.

Drew Hykes
Inari Medical Inc - CEO

Yeah. Good morning. Good to be with you all. First of all, thank you to JPMorgan for the invitation to participate this year. And thanks to all of you for your interest in the company. Here are disclosures. First thing you need to know about Inari Medical. The most important thing is that this is a mission-driven organization. And you can see that mission reflected here on this slide 3, really simple, but powerful ideas, which have served as the foundation for everything we have built up till now and really our North Star for all of our future plans.

It starts with putting patients first always. Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot